For decades, Body Mass Index (BMI) has been the standard tool for assessing overweight and obesity. However, its inability to distinguish between muscle and fat, account for body proportions, or accurately assess individuals across different ages and heights has long limited its clinical value. Researchers have now proposed a new anthropometric measure called the Consistent Body Mass Index (CBMI), designed to provide a more reliable and scalable assessment of body size. Unlike conventional BMI, CBMI closely aligns with the waist-to-height ratio, an increasingly recognized predictor of cardiometabolic risk, including type 2 diabetes, cardiovascular disease, and premature mortality. In a study involving 400 healthy participants spanning infancy to adulthood, CBMI demonstrated a stronger correlation with waist-to-height ratio than existing BMI alternatives, suggesting it may better reflect an individual's metabolic risk profile.

      The researchers also proposed preliminary CBMI classification ranges that closely matched waist-to-height ratio categories, potentially offering a more consistent approach to estimating ideal body weight and assessing obesity across different life stages. Nevertheless, the authors emphasize that CBMI is still an emerging research tool rather than a replacement for BMI. The proposed cut-offs require validation in larger and more diverse populations, and future studies must determine how well CBMI predicts body fat, diabetes, cardiovascular disease, and other health outcomes. If confirmed, this next-generation body index could complement or eventually improve upon traditional BMI, moving obesity assessment toward a more accurate, personalized, and clinically meaningful approach.